Plus, a quick look at Southwest Airlines and why it remains the one airline to own.
Monday's action in Johnson & Johnson is a fadeable event.
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.
Invest either because of their profitable portfolio, their impressive pipeline, or their technical set-up.
I know that Trump's going to blunt our community mask initiative because who needs masks if it isn't a big deal if you are sick?
AUPH has two very large market opportunities for its voclosporin drug.
Stocks of companies that have Covid-19 vaccine candidates have boomed while those in the treatment space have not.
Shares of Heron Therapeutics and Myovant Sciences have taken hits but both companies still show promise.
Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.